Droxidopa Capsule
Product Images NDC 70436-141

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 70436-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Droxidopa-structural-formula (Image 01)

Chemical structure diagram of droxidopa showing its molecular components including hydroxyl groups, an amino group, and a carboxylic acid group attached to a benzene ring.*

FDA Label Image

Droxidopa-figure1 (Image 02)

A line graph showing mean change in dizziness over 8 weeks during a double-blind treatment phase for droxidopa versus placebo. The Y-axis represents mean change in dizziness, with values decreasing downward. The X-axis marks weeks from baseline to week 8. Two lines compare droxidopa (solid) and placebo (dashed), showing a greater initial decrease in dizziness with droxidopa, and a statistically significant difference at week 1 (p<0.05). Error bars indicate variability at each time point.*

FDA Label Image

Droxidopa-figure2 (Image 03)

A bar graph showing the percent of subjects versus improvement in OHSA Question 1 scores, comparing droxidopa to placebo. The x-axis ranges from -8 (worse) to 8 (better), and the y-axis shows percent of subjects, with droxidopa represented by black bars and placebo by white bars. The graph visualizes the distribution of subject improvement scores for droxidopa and placebo groups.*

FDA Label Image

70436-140-06 (Image 04)

Droxidopa 100 mg capsules label from Slate Run Pharmaceuticals, LLC. The label indicates a package size of 90 capsules and includes dosage instructions, storage conditions, a barcode, and a warning to keep out of reach of children. The label specifies this is a prescription drug with oral route administration.*

FDA Label Image

70436-141-06 (Image 05)

Droxidopa 200 mg capsules packaging label from Slate Run Pharmaceuticals, LLC. The label shows the drug name, strength of 200 mg per capsule, and a package size of 90 capsules. It includes storage instructions, a caution to dispense in a tight, light-resistant container, and a warning to keep the product out of reach of children. The label also indicates prescription-only status and provides dosing and packaging details.*

FDA Label Image

70436-142-06 (Image 06)

Label for Droxidopa Capsules 300 mg by Slate Run Pharmaceuticals, LLC. The label includes dosage form as capsules with a package count of 90 capsules. It shows the strength of 300 mg per capsule, with storage instructions, usage warnings, and typical dosage directions, alongside barcodes and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.